Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.9B | 1.7B | 1.6B |
Cost of revenue | 548.3M | 617.8M | 459.8M | 486.0M |
Gross profit | 1.3B | 1.2B | 1.2B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 407.2M | 381.4M | 357.3M | 294.0M |
Operating income | 615.0M | 609.9M | 599.7M | 578.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 4.0M | 5.1M | 4.3M | 3.4M |
Other income expense | — | — | — | — |
Pretax income | 640.6M | 625.8M | 620.6M | 597.7M |
Tax provision | 136.8M | 158.0M | 159.2M | 151.3M |
Net income | 503.8M | 467.8M | 461.5M | 446.4M |
Basic EPS | — | 5.8 | 5.7 | 5.5 |
Diluted EPS | — | 5.8 | 5.7 | 5.5 |
Basic average shares | — | 80.4M | 80.8M | 80.6M |
Diluted average shares | — | 80.4M | 80.8M | 80.6M |
EBITDA | 705.4M | 680.5M | 672.4M | 647.7M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |